EP-104IAR

· Eupraxia Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EP-104IAR, covering 2024-06-25 to 2024-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the Knee [Phase 2]